课题基金 / 基金详情

Factors associated with persistent anal human papillomavirus infection among men

Factors associated with persistent anal human papillomavirus infection among men
男性持续性肛门人乳头瘤病毒感染的相关因素
批准号:
8601246
负责人:
ALAN GASPAR NYITRAY
金额:
$30.1万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-22 至 2014-07-31

项目摘要

项目成果

ALAN GASPAR NYITRAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Anal cancer is primarily caused by oncogenic human papillomavirus (HPV) types. Persistence of oncogenic HPV infection is the most important early biological event that marks increased risk for development of precancerous anal intraepithelial neoplasia. Annual anal cancer incidence among HIV-negative men having sex with men (MSM) in the US is several fold higher than cervical cancer incidence among women. It is unknown why only some MSM have persistent anal HPV infection and thus increased risk for anal cancer. Such data are especially critical now for two reasons: 1) current HPV vaccines have not been recommended for boys and men, and 2) current vaccines are not licensed for use among men older than 26 years of age. Thus, a fuller understanding of persistent anal HPV infection, is important for the development of anal cancer interventions among MSM. The Moffitt Cancer Center is uniquely positioned for this research as a result of its collection and archiving of anal canal specimens in the Human Papillomavirus in Men Study (HIM Study: NIH R01 CA098803 01), a longitudinal study investigating penile and scrotal HPV infections in men, ages 18-70 years. The HIM Study recruited men in Brazil, Mexico, and the United States beginning in 2005 and also added a post-award protocol to collect anal canal exfoliated cell specimens (anal canal specimen collection and testing was not funded by R01 CA098803 01). The proposed 2-year natural history study will analyze archived biological specimens and behavioral data from 950 men. The men included comprise two groups: all MSM with archived anal specimens (n=357) and a random sample of MSW with archived anal specimens (n=593). We hypothesize that anal HPV infection persistence in MSM is more common than in MSW and is associated with cigarette smoking among MSM. To test the hypothesis, we designed two Specific Aims: 1. Estimate persistence of type-specific anal HPV among MSM and MSW over a 24 month period; and 2. Determine factors independently associated with persistence of anal HPV including age, sexual behavior, cigarette smoking, concurrent sexually transmitted infections, and HPV antibodies. Given the infrastructure and sample size available with the HIM Study, the proposed research is powered to produce findings on HPV persistence that address fundamental questions related to anal cancer. Our proposed research will produce the first robust estimates of anal HPV persistence in MSM and MSW recruited cross-nationally from the general community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining the accuracy of self- and partner anal exams for detecting anal abnormalities.
  • 批准号:
    10468124
  • 项目类别:
  • 资助金额:
    $63.25万
  • 财政年份:
    2018
  • 负责人:
    ALAN GASPAR NYITRAY
  • 依托单位:
Determining the accuracy of self- and partner anal exams for detecting anal abnormalities.
  • 批准号:
    10252791
  • 项目类别:
  • 资助金额:
    $62.71万
  • 财政年份:
    2018
  • 负责人:
    ALAN GASPAR NYITRAY
  • 依托单位:
Determining the accuracy of self- and partner anal exams for detecting anal abnormalities.
  • 批准号:
    10006073
  • 项目类别:
  • 资助金额:
    $64.48万
  • 财政年份:
    2018
  • 负责人:
    ALAN GASPAR NYITRAY
  • 依托单位:
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
  • 批准号:
    10251869
  • 项目类别:
  • 资助金额:
    $49.91万
  • 财政年份:
    2017
  • 负责人:
    ALAN GASPAR NYITRAY
  • 依托单位:
国内基金
海外基金
V-K型CRISPR-associated transposase系统催化DNA定点插入的分子机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    陈美容
  • 依托单位:
Submesoscale Processes Associated with Oceanic Eddies
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    160万元
  • 批准年份:
    2022
  • 负责人:
    董昌明
  • 依托单位:
RAI16负调控肿瘤相关巨噬细胞c/EBPβ-TGF-β1通路抑制结直肠癌的机制研究
  • 批准号:
    32100629
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    丁翠玲
  • 依托单位:
CAFs源性TNFα上调口腔鳞癌HLA-E表达促进NK免疫逃逸的机制研究
  • 批准号:
    32000552
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王晓宁
  • 依托单位: